Our Presence

Scancell melanoma trial continues to yield ‘excellent results’

Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) said a further two people from a group of hard-to-treat melanoma patients in its SCOPE study have responded to its drug regimen, taking the number to 11 out of 13, or an objective response rate…

Proactive Investors | November 29, 2023

London-based biotech Leucid Bio raises £11.5M funding for hard-to-treat cancers

Based out of London, Leucid Bio is a pioneering biotech company working on next-generation cell therapies for hard-to-treat cancers. Recently, the company announced that it secured £11.5 million in a Series A funding round.

UKTN | September 25, 2023

PH startup CloudEats bags $5m from Vulpes, Gobi Partners and BAce Capital

PH startup CloudEats bags $5m from Vulpes, Gobi Partners

Deal Street Asia | September 25, 2023

These are the most active investors in Vietnam’s startups

Vulpes Ventures was named one of the most active investors in Vietnam’s startups by Tech in Asia

Tech in Asia | April 23, 2023

ThoughtFull gets $4M funding from Temasek’s Sheares, other tech founders

Singapore-based digital mental health company ThoughtFull has raised $4 million in a pre-Series A funding round led by Sheares Healthcare Group, a healthcare-focused investment entity under Temasek. The round was also joined by Vulpes Investment Management, The Hive Southeast Asia,…

Mobi Health News | March 23, 2023

Trader Who Made Billions in 2008 Refrains From Turmoil Bets

Steve Diggle, co-founder of volatility hedge fund Artradis Fund Management, which scored a $2.7 billion trading gain between 2007 and 2008, is sitting on the sidelines this time as bank woes rock markets.

Bloomberg | March 20, 2023

Subscribe to our newsletter to receive our latest news and updates!